Skip to content

Discontinued — last reported Q1 '26

Invested capital at other companies

Travel + Leisure logo
Travel + LeisureTNL
18.8%+0.1pp
Belden logo
BeldenBDC
12.2%+0.5pp
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
3.4%+1.8pp
Liberty Broadband Corporation logo
Liberty Broadband CorporationLBRDK
-0.3%-0.1pp
Archer Aviation logo
Archer AviationACHR
-129.7%-62.3pp
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
17.5%+14.2pp

Other financials

Income statement

See full
Operating income-$70.0M-47.5%
Net income-$69.7M-74.5%
EPS (diluted)-$0.98-55.6%

Balance sheet

See full
Cash & equivalents$298.5M+9.9%
Total debt$100.8M+33.3%
Total equity$254.0M-37.7%
Total assets$400.4M-21.7%

Cash flow

See full
Operating cash flow-$66.3M-73.8%
CapEx--100%
Free cash flow-$66.3M-73.6%

Valuation

See full
Market cap$1.49B-45.9%

Returns & leverage

See full
Return on equity-77.7%-221pp
Debt / equity0.4×+0.2×
Current ratio8.6×-12.5×

Where this comes from

Calculated from MoonLake Immunotherapeutics’s reported figures.

The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about MoonLake Immunotherapeutics's invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MoonLake Immunotherapeutics's invested capital?
MoonLake Immunotherapeutics (MLTX) reported invested capital of $56.34M in Q1 2026.
How has MoonLake Immunotherapeutics's invested capital changed year-over-year?
MoonLake Immunotherapeutics's invested capital decreased by 73.4% year-over-year, from $211.52M to $56.34M.
What is the long-term trend for MoonLake Immunotherapeutics's invested capital?
Over 4 years (2021 to 2025), MoonLake Immunotherapeutics's invested capital has grown at a 81.1% compound annual growth rate (CAGR), from -$4.25M to $45.67M.
What does invested capital mean?
Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).